The Oncology Institute, Inc. Common Stock (TOI) is a publicly traded Healthcare sector company. As of May 21, 2026, TOI trades at $4.17 with a market cap of $399.93M and a P/E ratio of -11.64. TOI moved +2.32% today. Year to date, TOI is +7.14%; over the trailing twelve months it is +51.08%. Its 52-week range spans $0.13 to $4.88. Analyst consensus is strong buy with an average price target of $7.00. Rallies surfaces TOI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The Oncology Institute, Inc. Common Stock (TOI) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TOI moved +2.32% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $4.17 |
| Market Cap | $399.93M |
| P/E Ratio | -11.64 |
| EPS | $-0.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.88 |
| 52-Week Low | $0.13 |
| Volume | 25 |
| Avg Volume | 0 |
| Revenue (TTM) | $545.76M |
| Net Income | $-43.51M |
| Gross Margin | 0.00% |
4 analysts cover TOI: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.00.